For the millions of people managing both obesity and obstructive sleep apnea (OSA), tirzepatide (Zepbound® and Mounjaro®, Eli Lilly and Co.) may offer a welcome approach to help reduce symptoms and improve overall health and quality of life. It’s been almost exactly a year since investigators of the SURMOUNT-OSA trial […]
Sleep Apnea
Belun Introduces New Features & Innovations in Sleep Monitoring
Belun is excited to share some important updates to the Belun Sleep Platform, designed to bring more insights and improved interface for clinicians and researchers in sleep medicine. The latest update introduces trend-plotting capability for patient data, allowing you to: Track longitudinal changes in sleep and physiological data; Visualize patient treatment progress over time; Support clinical decision-making […]
Hypoglossal Nerve Stimulation Patient Primer
There’s no one-size-fits-all approach for managing sleep apnea. Continuous positive airway pressure (CPAP) has been the go-to treatment for almost 40 years, but doctors have realized that some patients are not able to tolerate a CPAP mask or keep up with CPAP treatment over time. If you have a moderate […]
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
Inspire Medical Systems, Inc. published Inspire V clinical outcomes data from its Singapore clinical study, as well as the Company’s limited market release in the United States, including single-site experience at two leading centers. These data will be presented at the American Otolaryngology-Head and Neck Surgery (AAO-HNS) and International Surgical […]
Nylon flexTAP Becomes the First FDA-cleared 3D-Printed Midline Oral Appliance for Sleep Apnea
Airway Management proudly announces a historic milestone with the FDA clearance of Nylon flexTAP®, the world’s first digitally printed single-point midline oral appliance device for sleep apnea. This revolutionary device redefines patient care by combining cutting-edge patented Vertex Technology® with unparalleled comfort and efficacy, now FDA cleared for mild to moderate obstructive […]
Expert Insights: Dormotech Talks with Yale’s Dr. Meir Kryger on the Changing Landscape of Sleep Testing
Dormotech shares the release of a compelling expert highlight interview featuring Dr. Meir Kryger, Emeritus Professor at Yale School of Medicine. In this exclusive discussion, Dr. Kryger, a revered figure in the sleep industry who has been involved in sleep medicine since 1974, shares his unique perspective on the transformative […]
Patient Primer – Oral Appliance Therapy for Sleep Apnea
If your dentist or sleep physician has recommended oral appliance therapy to treat your obstructive sleep apnea (OSA), you might be wondering how it works. This guide walks you through the basics so you’ll know what to expect and how to get the best results. What Is a Mandibular Advancement […]
Nyxoah Receives FDA Approval for Genio System for Treatment of OSA
Nyxoah SA announced that the U.S. Food and Drug Administration (FDA) has approved the Genio system (hypoglossal nerve stimulation) for a subset of patients with moderate to severe OSA with an Apnea-Hypopnea Index (AHI) of greater than or equal to 15 and less than or equal to 65. Genio is […]
Navigating Insurance and Reimbursement
Insurance coverage and reimbursement for home sleep testing (HST) devices have improved in leaps and bounds over the last two decades, but unfortunately, denials and delays in care remain far too common. For many providers, figuring out a way forward can feel like navigating a labyrinth of policies and red […]
Dormotech Highlights the Critical Need for Early Pediatric Sleep Apnea Diagnosis with Insights from Dr. Asher Tal
Dormotech, a leader in advancing sleep diagnostics through innovative, clinically validated solutions, emphasized the urgent need for early and accessible diagnosis of sleep disorders in children. This critical focus echoes the profound insights shared by globally respected pediatric sleep medicine expert, Dr. Asher Tal. In an in-depth interview with Dormotech, […]













